Details the CEO buys this past week for the following companies: The GEO Group, AGNC Investment, Illinois Tool Works, Owl Rock Capital and OPKO Health Continue reading...
OPKO Health's (OPK) first-quarter performance is likely to reflect solid performance from Products and RAYALDEE.
BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the launch of COVID-19 antibody screening available to New York City residents in partnership with New York City Health and Hospital Corporation (NYC Health + Hospitals). Testing will initially be performed for 140,000 residents at five locations across all five boroughs, with more testing sites to open in the next several weeks. Test results will be available through BioReference's Patient Portal, accessible by smartphone, tablet, desktop or traditional US Mail and become available within 1-3 days, on average.
MIAMI, May 06, 2020 -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2020. Business Highlights.
OPKO Health (NASDAQ: OPK) lost more than half its value last year, but so far in 2020, the stock has soared more than 40%. Here are the highlights from OPKO's Q1 update. The good news is that OPKO's bottom line moved in a positive direction.
OPKO Health's (OPK) first-quarter results benefit from increase in RAYALDEE prescriptions.
OPKO Health's (OPK) subsidiary, BioReference Laboratories collaborates with MagnaCare to offer antibody testing to Labor groups in New York metropolitan area.
MIAMI, April 30, 2020 -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2020, as well as discuss financial.
MIAMI, May 27, 2020 -- OPKO Health, Inc. (NASDAQ: OPK) announced today that management will be participating in the Jefferies Virtual Healthcare Conference being held June.
BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today launched the BioReference Employer Solution, a COVID-19 screening program that assists employers' decisions about return-to-work policies.
OPKO Health, Inc. (OPK) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Its BioReference subsidiary is rolling out testing with five locations -- one in each of NYC's boroughs -- but will quickly expand its footprint.
As of late, it has definitely been a great time to be an investor in OPKO Health, Inc. (OPK).
MagnaCare today announced a collaboration with BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), to bring COVID-19 antibody testing to their Labor clients in the New York metropolitan area. Through this collaboration with BioReference, MagnaCare will offer on-site antibody blood testing to Labor members, delivering valuable information as the city, employers and individuals plan return-to-work strategies.
OPKO Health (OPK) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors
Investors need to pay close attention to OPKO Health (OPK) stock based on the movements in the options market lately.
After announcing it has launched a COVID-19 screening program to help employers make return-to-work decisions for employees, OPKO Health (NASDAQ: OPK) saw its shares close the day up more than 10% on Thursday. OPKO Health's BioReference Labs has been assisting healthcare providers with COVID-19 testing services since mid-March. On Monday, management expanded its COVID-19 product platform with the launch of an antibody test that can determine if someone has been exposed to the virus, and on Wednesday, the healthcare company unveiled services designed to inform business decisions relating to employees.
What happened After reporting a year-over-year decline in revenue that was worse than industry watchers expected, OPKO Health (NASDAQ: OPK) saw its shares fall 16.7% on Thursday. So what Although the healthcare company is benefiting from significant demand for COVID-19 tests, rising demand in the final weeks of the first quarter wasn't enough to offset declining demand for lab services caused by widespread shelter-in-place orders that reduced visits to primary- and specialty-care doctors.
Q1 2020 OPKO Health Inc Earnings Call
BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a strategic collaboration with the Westchester Medical Center Health Network (WMCHealth), a 1,700-bed healthcare system headquartered in Valhalla, New York, to provide full laboratory administrative services, laboratory operations, reference testing and outpatient laboratory services.